ABEONA THERAPEUTICS INC. (ABEO) › Operating IncomeABEONA THERAPEUTICS INC. (ABEO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$7.76M2011: -$7.88M2012: -$4.32M2013: -$3.80M2014: -$3.13M2015: -$18.55M2016: -$23.88M2017: -$27.84M2018: -$58.17M2019: -$77.09M2020: -$81.42M2021: -$89.84M2022: -$50.91M2023: -$47.13M2024: -$64.21M2025: -$89.45M-$89.45M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$89.45M-39.3%2024-$64.21M-36.2%2023-$47.13M+7.4%2022-$50.91M+43.3%2021-$89.84M-10.3%2020-$81.42M-5.6%2019-$77.09M-32.5%2018-$58.17M-109.0%2017-$27.84M-16.6%2016-$23.88M-28.8%2015-$18.55M-492.3%2014-$3.13M+17.7%2013-$3.80M+11.9%2012-$4.32M+45.2%2011-$7.88M-1.5%2010-$7.76M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share